SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (5919)10/25/1998 11:29:00 PM
From: Cacaito  Read Replies (2) of 7041
 
This is my view of the Irving Goldstein presentation months ago, just refreshing:

www3.techstocks.com

Clever ways, but data massage post unblinding is not a good FDA way.

Check the ERGO debacle, they got a NO from the recommendations advisory board (FDA is not binding to this, but the stock from $18 to $2).

But believers are hanging tough, closing a short position here is good idea, then open it back at higher prices. The acceptance of the NDA should be soon in the next few weeks (2 months from application). This is the only short term breath, after that to way 6 months for fast track (this is pure bureaucracy, nothing to do with real urgent needs), or the usual 1 to 2 years. If Schering is strong behind this then fast track is a very real possibility.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext